Shinagawa R&D Center, Tokyo

Shinagawa R&D Center has created various innovative new medicines over the years as the center of research and development of Daiichi Sankyo and delivered them to medical sites and patients. We are promoting drug discovery research, non-clinical research, and translational research, with the aim of promoting disease research with cutting-edge science and technology and creating innovative pharmaceuticals through the Multi-modality strategy. We are also promoting global clinical development collaboratively working with Daiichi Sankyo Pharma Development in USA and related divisions of such as biologics, pharmaceutical technology, and quality assurance. Furthermore, it promotes clinical trials seamlessly with the development department of Daiichi Sankyo RD Novare, and also plays the role of supervising the development department of East Asia's group companies as a clinical development base in the East region.

Kasai R&D Center, Tokyo

Kasai RD Center leads safety research and vaccine research, and Daiichi Sankyo RD Novare promotes drug discovery research on a state-of-the-art technology platform for non-clinical research and a translational research platform centered  on a clinical sample analysis facility.

Tatebayashi Biologics Technology Development Center, Gunma prefecture

Tatebayashi Biologics Technology Development Center is leading research in the development of biopharmacy manufacturing processes that require advanced technology and makes sure high-quality biopharmacy can stably delivered to patients.

Hiratsuka Pharmaceutical Technology Development Center, Kanagawa prefecture

Hiratsuka Pharmaceutical Technology Development Center leads research on manufacturing process development and quality evaluation of APIs and drug products to ensure high-quality new drugs can be stably delivered to patients, and deals with regulatory affairs with regulatory authorities on manufacturing and quality. 

Daiichi Sankyo Pharma Development/Daiichi Sankyo, Inc., New Jersey, USA

Daiichi Sankyo Pharma Development (DSPD) leads planning, strategies, and operations for global clinical development in collaboration with the clinical development in Japan and related global departments.

Pharmaceutical Development/Daiichi Sankyo Europe GmbH, Pfaffenhofen, Germany

Pharmaceutical development in Pfaffenhofen conducts research on manufacturing process development and quality evaluation of biopharmaceuticals and drug products, to ensure high-quality new drugs can be stably delivered to patients, and to deal with regulatory affairs with regulatory authorities on manufacturing and quality.

Tissue & Cell Research Center/Daiichi Sankyo Europe GmbH, Munich, Germany

Together with the members of the research department of the Shinagawa R&D Center, we mainly conduct pharmacokinetic tests studies  and translational research using human tissues.